Skip Navigation LinksHome > March 2011 - Volume 111 - Issue 3 > New Antibiotic for MRSA and Pneumonia
AJN, American Journal of Nursing:
doi: 10.1097/10.1097/01.NAJ.0000395236.76228.89
Drug Watch

New Antibiotic for MRSA and Pneumonia

Aschenbrenner, Diane S. MS, RN

Collapse Box


* A new cephalosporin, ceftaroline fosamil (Teflaro), has been approved to treat acute bacterial skin infections caused by methicillin-resistant Staphylococcus aureus, as well as serious community-acquired bacterial pneumonia requiring hospitalization.

* Ceftaroline fosamil is administered as an IV infusion.

© 2011 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics